ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $799 | -29.7% | 505,993 | -3.9% | 0.00% | -50.0% |
| Q2 2023 | $1,137 | +243.5% | 526,355 | +233.9% | 0.00% | – |
| Q1 2023 | $331 | -9.1% | 157,655 | -5.1% | 0.00% | – |
| Q4 2022 | $364 | -99.9% | 166,076 | -11.4% | 0.00% | -100.0% |
| Q3 2022 | $563,000 | +31.9% | 187,525 | +24.3% | 0.00% | 0.0% |
| Q2 2022 | $427,000 | -28.0% | 150,825 | +36.1% | 0.00% | 0.0% |
| Q1 2022 | $593,000 | -37.6% | 110,855 | -12.8% | 0.00% | 0.0% |
| Q4 2021 | $950,000 | -41.8% | 127,155 | -29.2% | 0.00% | -50.0% |
| Q3 2021 | $1,631,000 | +89.7% | 179,655 | +1.9% | 0.00% | +100.0% |
| Q2 2021 | $860,000 | -20.1% | 176,255 | -27.2% | 0.00% | 0.0% |
| Q1 2021 | $1,077,000 | -13.0% | 241,960 | -24.2% | 0.00% | 0.0% |
| Q4 2020 | $1,238,000 | -6.1% | 319,130 | -21.9% | 0.00% | 0.0% |
| Q3 2020 | $1,319,000 | -18.8% | 408,430 | +11.6% | 0.00% | 0.0% |
| Q2 2020 | $1,624,000 | +177.6% | 365,830 | +75.0% | 0.00% | 0.0% |
| Q1 2020 | $585,000 | -29.9% | 209,000 | +4.5% | 0.00% | 0.0% |
| Q4 2019 | $834,000 | +23.0% | 199,920 | +3.3% | 0.00% | 0.0% |
| Q3 2019 | $678,000 | – | 193,620 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 4,626,624 | $7,310,066 | 2.43% |
| Tikvah Management LLC | 2,460,833 | $3,888,116 | 1.40% |
| TANG CAPITAL MANAGEMENT LLC | 471,134 | $744,392 | 0.10% |
| FEDERATED HERMES, INC. | 10,169,600 | $16,067,968 | 0.04% |
| Alyeska Investment Group, L.P. | 2,455,555 | $3,879,777 | 0.03% |
| XTX Topco Ltd | 73,894 | $116,753 | 0.02% |
| ALTERNA WEALTH MANAGEMENT, INC | 10,000 | $15,800 | 0.02% |
| Pale Fire Capital SE | 55,857 | $88,254 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 27,559 | $44 | 0.00% |
| Virtu Financial LLC | 13,662 | $22 | 0.00% |